drugset
drugset / Trial / NCT02926326

The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers

NCT02926326 ↗

Phase 1 Completed 16 enrolled Mereo BioPharma
NaSingle-groupOpen-labelTreatment

Summary

An open-label, single-sequence study to evaluate the effect of azithromycin on BCT197 exposure in healthy male subjects.

Timeline

Start
2016-09
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Acumapimod Small molecule 14 mg —
Subject Azithromycin Small molecule 500 mg —

Indications

No indication recorded.